A New Specific DNA Target Sequence for Identification of Staphylococcus epidermidis using Modified Comparative Genomic Analysis
Copyright© 2022 Avicenna Research Institute..
Background: Staphylococcus epidermidis (S. epidermidis) is the most frequently isolated pathogen from prostheses infections in the body. Therefore, improving its diagnostic methods, including rapid Nucleic Acid Amplification Tests (NAAT), seems necessary. Since the first step in designing a NAAT is to find a specific sequence and all DNA targets that have been introduced so far are not completely specific, we introduced a new 100% specific DNA target sequence to identify S. epidermidis in this study.
Methods: Modified comparative genomic analysis was used to find the best specific target sequence to detect S. epidermidis. A PCR method was designed for the evaluation of this target. To determine the detection limit and analytical specificity, pure genomic DNA of 18 bacteria include 12 standard strains (one S. epidermidis and 11 non-S. epidermidis) and six clinical isolates (five S. epidermidis and one non-S. epidermidis) were used.
Results: The 400 bp sequence of S. epidermidis ATCC 14990 was identified as the most specific sequence (Se400), having a 100% sequence similarity to S. epidermidis genomes but not with other bacteria. The detection limit of Se400-PCR was 10 fg, equal to about 4 copies of S. epidermidis genomic DNA/μl. All pure DNA templates from S. epidermidis generated a detectable amplicon by 264 bp length, but the PCR test was negative for the non-S. epidermidis group.
Conclusion: The Se400 sequence can be considered as a specific target for detecting S. epidermidis, based on our findings.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Avicenna journal of medical biotechnology - 14(2022), 3 vom: 29. Juli, Seite 216-222 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khoshbakht, Reza [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comparative genomic analysis |
|---|
| Anmerkungen: |
Date Revised 07.09.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18502/ajmb.v14i3.9828 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345783441 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345783441 | ||
| 003 | DE-627 | ||
| 005 | 20231226025846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18502/ajmb.v14i3.9828 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM345783441 | ||
| 035 | |a (NLM)36061130 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khoshbakht, Reza |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A New Specific DNA Target Sequence for Identification of Staphylococcus epidermidis using Modified Comparative Genomic Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.09.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright© 2022 Avicenna Research Institute. | ||
| 520 | |a Background: Staphylococcus epidermidis (S. epidermidis) is the most frequently isolated pathogen from prostheses infections in the body. Therefore, improving its diagnostic methods, including rapid Nucleic Acid Amplification Tests (NAAT), seems necessary. Since the first step in designing a NAAT is to find a specific sequence and all DNA targets that have been introduced so far are not completely specific, we introduced a new 100% specific DNA target sequence to identify S. epidermidis in this study | ||
| 520 | |a Methods: Modified comparative genomic analysis was used to find the best specific target sequence to detect S. epidermidis. A PCR method was designed for the evaluation of this target. To determine the detection limit and analytical specificity, pure genomic DNA of 18 bacteria include 12 standard strains (one S. epidermidis and 11 non-S. epidermidis) and six clinical isolates (five S. epidermidis and one non-S. epidermidis) were used | ||
| 520 | |a Results: The 400 bp sequence of S. epidermidis ATCC 14990 was identified as the most specific sequence (Se400), having a 100% sequence similarity to S. epidermidis genomes but not with other bacteria. The detection limit of Se400-PCR was 10 fg, equal to about 4 copies of S. epidermidis genomic DNA/μl. All pure DNA templates from S. epidermidis generated a detectable amplicon by 264 bp length, but the PCR test was negative for the non-S. epidermidis group | ||
| 520 | |a Conclusion: The Se400 sequence can be considered as a specific target for detecting S. epidermidis, based on our findings | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comparative genomic analysis | |
| 650 | 4 | |a Detection | |
| 650 | 4 | |a Pathogen | |
| 650 | 4 | |a Polymerase chain reaction | |
| 650 | 4 | |a Se400 | |
| 650 | 4 | |a Staphylococcus epidermidis | |
| 700 | 1 | |a Zare, Hosna |e verfasserin |4 aut | |
| 700 | 1 | |a Kamali Kakhki, Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Neshani, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Arfaatabar, Maryam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Avicenna journal of medical biotechnology |d 2009 |g 14(2022), 3 vom: 29. Juli, Seite 216-222 |w (DE-627)NLM225002876 |x 2008-2835 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:3 |g day:29 |g month:07 |g pages:216-222 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18502/ajmb.v14i3.9828 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2022 |e 3 |b 29 |c 07 |h 216-222 | ||